Summary
Medtronic plc (MDT) has filed an 8-K report on August 20, 2024, furnishing a press release detailing its first-quarter fiscal year 2025 financial results. This filing is crucial for investors as it provides the latest performance data for the company. While the 8-K itself doesn't contain the detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for the specific revenue, profit, and segment performance numbers. Investors should review this press release to understand Medtronic's current financial health and operational achievements for the quarter ending in July 2024.
Key Highlights
- 1Medtronic plc announced its first quarter fiscal year 2025 financial results via a press release.
- 2The press release, dated August 20, 2024, is furnished as an exhibit (Exhibit 99.1) to the 8-K filing.
- 3This filing serves as the official notification of the company's latest financial performance.
- 4Investors need to refer to the press release for detailed Q1 FY2025 financial data.
- 5The report indicates the event date for the financial results announcement was August 19, 2024.
Frequently Asked Questions
The primary purpose of this 8-K filing is to officially announce and provide access to Medtronic plc's first-quarter fiscal year 2025 financial results through an accompanying press release.
The detailed financial results are contained within the press release dated August 20, 2024, which is furnished as Exhibit 99.1 to this 8-K filing.
This report covers Medtronic plc's financial results for the first quarter of its fiscal year 2025.
No, the 8-K filing itself does not contain the specific financial numbers. It serves to inform investors that the results have been released and directs them to the furnished press release (Exhibit 99.1) for the detailed financial information.